Advertisement

International Journal of Hematology

, Volume 84, Issue 4, pp 367–376 | Cite as

Expression of CD27 on Peripheral CD4+ T-Lymphocytes Correlates with the Development of Severe Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation

  • Hitoshi Yoshida
  • Tetsuo Maeda
  • Jun Ishikawa
  • Shinya Inoue
  • Hitomi Matsunaga
  • Satoru Kosugi
  • Masamichi Shiraga
  • Kenji Oritani
  • Yuzuru Kanakura
  • Yoshiaki Tomiyama
Article

Abstract

Allogeneic immune responses during hematopoietic reconstitution play central roles in beneficial and adverse effects after allogeneic bone marrow transplantation (allo-BMT).Appropriate regulation of the immune responses might improve the outcome of allo-BMT. However, a useful marker for monitoring allogeneic immune responses remains to be established. We enrolled 22 consecutive patients who underwent myeloablative allo-BMT between March 2002 and March 2006 and examined the relationship between CD27 expression on peripheral blood T-lymphocytes, a possible marker for naive/effector pheno-types, and clinical events, especially acute graft-versus-host disease (aGVHD). In 8 patients with aGVHD of grades II to IV, the CD27+/CD27- ratios of CD4+ (but not CD8+) T-lymphocytes were significantly higher after allo-BMT, even at day 21, than the ratios in patients with aGVHD of grade 0 or I and remained high after day 21. In contrast, the ratios were low after day 21 following allo-BMT in 14 patients with aGVHD of grade 0 or I. Moreover, the clinical analysis suggested a relationship between the ratio and aGVHD grade. Thus, we showed that the CD27+/CD27- ratio in CD4+ T-lymphocytes may have value in predicting the development of severe aGVHD and may correlate with clinical symptoms of aGVHD.

Key words

Allogeneic bone marrow transplantation Acute GVHD CD4+ T-lymphocytes CD27+/CD27- ratio Prediction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Peggs KS, Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol. 2004;124:407–420.CrossRefPubMedGoogle Scholar
  2. 2.
    Kolb H-J, Schmid C, Barrett J, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood. 2004;103:767–776.CrossRefPubMedGoogle Scholar
  3. 3.
    Theobald M. Allorecognition and graft-versus-host disease. Bone Marrow Transplant. 1995;15:489–498.PubMedGoogle Scholar
  4. 4.
    Ferrara JLM. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effects. J Hematother Stem Cell Res. 2000;9:299–306.CrossRefPubMedGoogle Scholar
  5. 5.
    Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol. 2001;29:259–277.CrossRefPubMedGoogle Scholar
  6. 6.
    Riddell SR. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect. 1995;10:199–208.PubMedGoogle Scholar
  7. 7.
    Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant. 2000;6:44–49.CrossRefPubMedGoogle Scholar
  8. 8.
    Lens SMA, Tesselaar K, van Oers MHJ, van Lier RA. Control of lymphocyte function through CD27-CD70 interaction. Semin Immunol. 1998;10:491–499.CrossRefPubMedGoogle Scholar
  9. 9.
    Hintzen RQ, van Lier RAW, Lens SMA, Brouwer M, Baars P, van Lier RAW. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol. 1993;151:2426–2435.PubMedGoogle Scholar
  10. 10.
    Hamman P, Baars PA, Rep MH, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186:1407–1418.CrossRefGoogle Scholar
  11. 11.
    Lens SMA, de Joug R, Hooibrink B, et al. Phenotype and functions of human B cells expressing CD70 (CD27L). Eur J Immunol. 1996;26:2964–2971.CrossRefPubMedGoogle Scholar
  12. 12.
    Lens SMA, Baar PA, Hooibrink B, van Oers MHJ, van Lier RAW. Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells. Immunology. 1997;90:38–45.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hintzen RQ, Lens SMA, Lammers K, et al. Engagement of CD27 with its ligand (CD70) provides a second signal for T-cell activation. J Immunol. 1995;154:2612–2623.PubMedGoogle Scholar
  14. 14.
    Brown GR, Meek K, Nishioka Y, Thiele DL. CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes. J Immunol. 1995;154:3689–95.Google Scholar
  15. 15.
    Chamnleau MED, ten Berge IJM, Schellekens PTA, Wilmink JM, Hintzen RQ, van Lier RAW. Serum levels of soluble CD27 in renal transplant recipients. Transplantation. 1992;54:932–936.CrossRefGoogle Scholar
  16. 16.
    Yazdanbakhsh M, Sartono E, Kruize YCM, et al. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol. 1993;22:993–999.Google Scholar
  17. 17.
    Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825–828.Google Scholar
  18. 18.
    McNeel D, Rubio MT, Damaj G, et al. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation. 2002;74:1797–1800.CrossRefGoogle Scholar
  19. 19.
    Liem LM, van Lopik T, van Nieuwenhuijze AEM, van Houwelingen HC, Aarden L, Goulmy E. Souluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections. Blood. 1998;91:1464–1468.Google Scholar
  20. 20.
    Kami M, Matsumura T, Tanaka Y, et al. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease. Leuk Lymphoma. 2000;38:533–540.CrossRefPubMedGoogle Scholar
  21. 21.
    Heitger A, Greinix H, Mannhalter C, et al. Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation. 2000;69:2366–2373.CrossRefPubMedGoogle Scholar
  22. 22.
    Miyamoto T, Akashi K, Hayashi S, et al. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant. 1996;17:185–190.PubMedGoogle Scholar
  23. 23.
    Mathias C, Mick R, Grupp S, et al. Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation. J Hematother Stem Cell Res. 2000;9:393–400.CrossRefPubMedGoogle Scholar
  24. 24.
    Hintzen RQ, de Joug R, Hack CE, et al. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol. 1991;147:29–35.PubMedGoogle Scholar
  25. 25.
    Hebib NC, Deas O, Rouleau M, et al. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profile. Blood. 1999;94:1803–1813.PubMedGoogle Scholar
  26. 26.
    Lin M-T, Tseng L-H, Frabgoul H, et al. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood. 2000;95:3832–3839.PubMedGoogle Scholar
  27. 27.
    Horikawa M, Matsunai T, Saitoh H, et al. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002;30:915–923.CrossRefGoogle Scholar
  28. 28.
    Margolis DA, Casper JT, Segura AD, et al. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant. 2000;6:408–415.CrossRefPubMedGoogle Scholar
  29. 29.
    Anderson BE, McNiff J, Yan J, et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112:101–108.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Chen BJ, Cui X, Sempowski GD, Liu C, Chao N. Transfer of allo-geneic CD62L- memory T cells without graft-versus-host disease. Blood. 2004;103:1534–1541.CrossRefPubMedGoogle Scholar
  31. 31.
    Lampert IA, Suitters AJ, Chisholm PM. Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease. Nature. 1981;293:149–150.CrossRefPubMedGoogle Scholar
  32. 32.
    Mason DW, Dallman M, Barcloug AN. Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium. Nature. 1981;293:150–151.CrossRefPubMedGoogle Scholar
  33. 33.
    Jones SC, Murphy GF, Friedman TM, Korngold R. Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease. J Clin Invest. 2003;112:1880–1886.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Dutt S, Emann J, Tseng D, et al. L-selectin and β7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 2005;106:4009–4015.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Yu X-Z, Albert MH, Anasetti C. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells. J Immunol. 2006;176:3383–3390.CrossRefPubMedGoogle Scholar
  36. 36.
    De Rosa SC, Herzenberg LA, Roederer M. 11-color 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med. 2001;7:245–248.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2006

Authors and Affiliations

  • Hitoshi Yoshida
    • 1
  • Tetsuo Maeda
    • 1
  • Jun Ishikawa
    • 1
  • Shinya Inoue
    • 1
  • Hitomi Matsunaga
    • 1
  • Satoru Kosugi
    • 1
  • Masamichi Shiraga
    • 1
  • Kenji Oritani
    • 1
  • Yuzuru Kanakura
    • 1
  • Yoshiaki Tomiyama
    • 1
  1. 1.Department of Hematology and Oncology, Graduate School of MedicineC9, Osaka UniversityOsakaJapan

Personalised recommendations